Cabio Accounts Payable from 2010 to 2025

688089 Stock   18.03  0.06  0.33%   
Cabio Biotech's Accounts Payable is increasing over the years with slightly volatile fluctuation. Overall, Accounts Payable is expected to go to about 85.6 M this year. Accounts Payable is the amount Cabio Biotech Wuhan owes to suppliers or vendors for products or services received but not yet paid for. It represents Cabio Biotech's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-06-30
Previous Quarter
64 M
Current Value
70.1 M
Quarterly Volatility
26.6 M
 
Covid
Check Cabio Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabio Biotech's main balance sheet or income statement drivers, such as Tax Provision of 17.8 M, Net Interest Income of 1.7 M or Interest Expense of 856.9 K, as well as many indicators such as . Cabio financial statements analysis is a perfect complement when working with Cabio Biotech Valuation or Volatility modules.
  
This module can also supplement various Cabio Biotech Technical models . Check out the analysis of Cabio Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cabio Stock

Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.